Cargando…
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
OnabotulinumtoxinA, a neurotoxin, has been studied in numerous trials as a novel preventive therapy for migraine headache. The data would support that it may be effective at reducing headache days in patients suffering from chronic migraine (≥15 headache days/month, with eight or more of those migra...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261651/ https://www.ncbi.nlm.nih.gov/pubmed/22275844 http://dx.doi.org/10.2147/NDT.S17923 |